Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-30

Study Completion Date

2019-09-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the impact of different nicotine levels in cigarettes with individuals who have ADHD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Contingency Management, Quitting Smoking, and ADHD

NCT02266784

Cigarette Smoking Smoking Cessation

COMPLETED PHASE1

Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior

NCT03840694

Cigarette Smoking Nicotine Withdrawal

TERMINATED NA

Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

NCT02989038

Nicotine Dependence

COMPLETED NA

Contingency Management for Smoking Abstinence With Adolescent Smokers

NCT01056588

Cigarette Smoking

COMPLETED NA

Predictors of Teen Smoking-cessation

NCT01141517

Cigarette Smoking

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to examine the effects of very low nicotine content (VLNC) cigarettes on smoking behavior, psychiatric symptoms and functioning, and acceptability and adverse outcomes in young adult smokers with ADHD. Participants will attend a screening session, 2 baseline sessions, 6 experimental sessions, and a 30 day follow-up visit. Participants will be asked to smoke only the study cigarettes that we provide for 6 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nicotine Dependence ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Very low nicotine content cigarettes

Reduced nicotine content cigarettes.

Group Type OTHER

Very low nicotine content cigarettes

Intervention Type OTHER

Cigarettes containing a reduced amount of nicotine

Conventional nicotine content cigarettes

Intervention Type OTHER

Cigarettes containing a normal amount of nicotine

Conventional nicotine content cigarettes

Conventional nicotine content cigarettes.

Group Type OTHER

Very low nicotine content cigarettes

Intervention Type OTHER

Cigarettes containing a reduced amount of nicotine

Conventional nicotine content cigarettes

Intervention Type OTHER

Cigarettes containing a normal amount of nicotine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Very low nicotine content cigarettes

Cigarettes containing a reduced amount of nicotine

Intervention Type OTHER

Conventional nicotine content cigarettes

Cigarettes containing a normal amount of nicotine

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tobacco Cigarettes Tobacco Cigarettes

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 - 40
* Smoke an average of 5-40 cigarettes per day for at least 1 year
* Breath CO levels \> 8 ppm (if ≤ 8 ppm, then NicAlert Strip \> 6)
* Primary diagnosis of ADHD, any subtype as assessed by the CAADID; T-Score \> 65 on one of the DSM- V relevant scales (Inattentive Symptoms, Hyperactive-Impulsive Symptoms, Total Symptoms or ADHD Index) on the Self-Report version of the CAARS; Clinician Rated ADHD-RS score \>24.
* Cognitive functioning \> 80 as assessed by the KBIT-II

Exclusion Criteria

* Intention to quit smoking in the next 30 days
* Currently seeking treatment for smoking cessation
* Currently using nicotine replacement therapies or other pharmacotherapies as cessation aid (intermittent use acceptable)
* A quit attempt in the past 30 days resulting in greater than 3 days of abstinence
* Using other tobacco products more than 9 days in the past 30 days
* Significant unstable medical conditions (any significant change in a serious medical condition occurring during the past 3 months including cardiovascular disease, COPD, and cancer, as determined by the study physician at each site)
* Significant unstable psychiatric conditions (any significant change in psychiatric symptoms during the past 3 months as determined by the study physician at each site)
* Any Axis I Psychiatric Disorder as assessed by the MINI that is significantly impairing and/or would contraindicate participation in the study
* Psychiatric medication changes in the past 3 months including new prescriptions, changes in dosages or discontinuation of medications
* Positive toxicology screen for any of the following drugs: cocaine, opiates, methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP (Marijuana will be tested for but will not be an exclusionary criterion, participants with valid prescriptions for opiates, benzodiazepines, barbiturates, amphetamines or methadone will not be excluded, participants failing the toxicology screen will be allowed to re-screen once. These participants will need to be re-consented before being rescreened to ensure they have received adequate informed consent.)
* Breath alcohol level \> 0.01 (Participants failing the breath alcohol screen will be allowed to re-screen once. These participants will need to be re-consented before being rescreened to ensure they have received adequate informed consent.)
* Current diagnosis of DSM alcohol or drug use disorder (except for nicotine)
* Pregnant, trying to become pregnant or breastfeeding
* Smoking 'roll your own cigarettes' exclusively
* Currently taking anticonvulsant medications including: Phenytoin \[Brand Name: Dilantin\], Carbamazepine \[Brand Name: Tegretol, Carbatrol, Equetro, Epitol\], Oxcarbazepine \[Brand Name: Trileptal\], Primidone \[Brand Name: Mysoline\], Phenobarbital
* CO reading \>80 ppm
* Systolic BP between 90 and 160 (If below 90 then asymptomatic. Participants failing for blood pressure will be allowed to re-screen once.)
* Diastolic BP between 50 and 100 (If below 50 then asymptomatic. Participants failing for blood pressure will be allowed to re-screen once.)
* Heart rate between 45 and 115 bpm (If below 45 then asymptomatic. Participants failing for heart rate will be allowed to re-screen once.)
* Indicating any suicidal ideation in the past month or suicide attempts in the past 10 years.
* Inability to independently read and comprehend the consent form and other written study materials and measures.
* Having participated in a research study during the past three months in which the participant: Smoked a cigarette that was not his/her usual brand cigarette for more than one day, used any tobacco products beyond normal use for more than one day, used any nicotine replacement products or smoking cessation medications for more than one day
* Any previous experience using SPECTRUM cigarettes

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes